| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ |
|---|---|---|---|---|
| Revenue | $15.1B | $16.1B | $17.0B | $18.7B |
| Cost of Revenue | $11.9B | $13.2B | $14.5B | $16.6B |
| Gross Profit | — | — | — | — |
| R&D Expense | $0.0B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $2.6B | $2.8B | $2.9B | $2.8B |
| Operating Income | — | — | — | — |
| Net Income | $0.3B | $-0.3B | $-1.4B | $-2.3B |
| EPS (Basic) | $1.09 | $-1.48 | $-6.06 | $-10.35 |
| EPS (Diluted) | $1.05 | $-1.48 | $-6.06 | $-10.35 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ |
|---|---|---|---|---|
| Total Assets | $10.5B | $10.6B | $11.5B | $13.2B |
| Current Assets | $4.6B | $4.7B | $5.0B | $5.8B |
| Cash & Equivalents | $1.8B | $1.6B | $1.8B | $2.2B |
| Total Liabilities | $9.1B | $9.5B | $10.0B | $10.5B |
| Current Liabilities | $4.3B | $4.6B | $4.9B | $4.5B |
| Stockholders' Equity | $1.2B | $1.0B | $1.4B | $2.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ |
|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.5B | $0.8B | $-0.1B |
| Investing Cash Flow | $-0.4B | $-0.6B | $-0.8B | $-0.6B |
| Capital Expenditures | — | — | — | $0.8B |
| Financing Cash Flow | $-0.3B | $-0.2B | $-0.1B | $2.9B |